Advertisement
Advertisement

SION

SION logo

Sionna Therapeutics, Inc. Common Stock

42.42
USD
Sponsored
-0.02
-0.05%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

42.24

-0.17
-0.41%

SION Earnings Reports

Positive Surprise Ratio

SION beat 2 of 4 last estimates.

50%

Next Report

Date of Next Report
Mar 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.55
Implied change from Q3 25 (Revenue/ EPS)
--
/
+19.57%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-83.73%

Sionna Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, SION reported earnings of -0.46 USD per share (EPS) for Q3 25, beating the estimate of -0.49 USD, resulting in a 6.88% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.55 USD, with revenue projected to reach -- USD, implying an increase of 19.57% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Sionna Therapeutics, Inc. Common Stock reported EPS of -$0.46, beating estimates by 6.88%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.57%, changed from $35.64 before the earnings release to $35.08 the day after.
The next earning report is scheduled for Mar 16, 2026.
Based on 11 analysts, Sionna Therapeutics, Inc. Common Stock is expected to report EPS of -$0.55 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement